ADME Toxicology Testing Market Size, Top Share And Future Growth Prospects by 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global ADME Toxicology Testing Market Size Analysis

Global ADME Toxicology Testing Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Cell Culture Technology
  1. By Value
3. High-Throughput Screening (HTS)
  1. By Value
4. Molecular Imaging Technology
  1. By Value
5. OMICS Technology
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Cellular Assay
  1. By Value
3. Biochemical Assay
  1. By Value
4. In-Silico
  1. By Value
5. Ex-Vivo
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Systemic Toxicity
  1. By Value
3. Renal Toxicity
  1. By Value
4. Hepatotoxicity
  1. By Value
5. Neurotoxicity
  1. By Value
6. Other Toxicities
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Cell Culture Technology
  1. By Value
3. High-Throughput Screening (HTS)
  1. By Value
4. Molecular Imaging Technology
  1. By Value
5. OMICS Technology
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Cellular Assay
  1. By Value
3. Biochemical Assay
  1. By Value
4. In-Silico
  1. By Value
5. Ex-Vivo
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Systemic Toxicity
  1. By Value
3. Renal Toxicity
  1. By Value
4. Hepatotoxicity
  1. By Value
5. Neurotoxicity
  1. By Value
6. Other Toxicities
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Cell Culture Technology
    1. By Value
  3. High-Throughput Screening (HTS)
    1. By Value
  4. Molecular Imaging Technology
    1. By Value
  5. OMICS Technology
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Cellular Assay
    1. By Value
  3. Biochemical Assay
    1. By Value
  4. In-Silico
    1. By Value
  5. Ex-Vivo
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Systemic Toxicity
    1. By Value
  3. Renal Toxicity
    1. By Value
  4. Hepatotoxicity
    1. By Value
  5. Neurotoxicity
    1. By Value
  6. Other Toxicities
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Cell Culture Technology
  1. By Value
3. High-Throughput Screening (HTS)
  1. By Value
4. Molecular Imaging Technology
  1. By Value
5. OMICS Technology
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Cellular Assay
  1. By Value
3. Biochemical Assay
  1. By Value
4. In-Silico
  1. By Value
5. Ex-Vivo
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Systemic Toxicity
  1. By Value
3. Renal Toxicity
  1. By Value
4. Hepatotoxicity
  1. By Value
5. Neurotoxicity
  1. By Value
6. Other Toxicities
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Cell Culture Technology
    1. By Value
  3. High-Throughput Screening (HTS)
    1. By Value
  4. Molecular Imaging Technology
    1. By Value
  5. OMICS Technology
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Cellular Assay
    1. By Value
  3. Biochemical Assay
    1. By Value
  4. In-Silico
    1. By Value
  5. Ex-Vivo
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Systemic Toxicity
    1. By Value
  3. Renal Toxicity
    1. By Value
  4. Hepatotoxicity
    1. By Value
  5. Neurotoxicity
    1. By Value
  6. Other Toxicities
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Cell Culture Technology
  1. By Value
3. High-Throughput Screening (HTS)
  1. By Value
4. Molecular Imaging Technology
  1. By Value
5. OMICS Technology
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Cellular Assay
  1. By Value
3. Biochemical Assay
  1. By Value
4. In-Silico
  1. By Value
5. Ex-Vivo
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Systemic Toxicity
  1. By Value
3. Renal Toxicity
  1. By Value
4. Hepatotoxicity
  1. By Value
5. Neurotoxicity
  1. By Value
6. Other Toxicities
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Cell Culture Technology
    1. By Value
  3. High-Throughput Screening (HTS)
    1. By Value
  4. Molecular Imaging Technology
    1. By Value
  5. OMICS Technology
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Cellular Assay
    1. By Value
  3. Biochemical Assay
    1. By Value
  4. In-Silico
    1. By Value
  5. Ex-Vivo
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Systemic Toxicity
    1. By Value
  3. Renal Toxicity
    1. By Value
  4. Hepatotoxicity
    1. By Value
  5. Neurotoxicity
    1. By Value
  6. Other Toxicities
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Cell Culture Technology
  1. By Value
3. High-Throughput Screening (HTS)
  1. By Value
4. Molecular Imaging Technology
  1. By Value
5. OMICS Technology
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Cellular Assay
  1. By Value
3. Biochemical Assay
  1. By Value
4. In-Silico
  1. By Value
5. Ex-Vivo
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Systemic Toxicity
  1. By Value
3. Renal Toxicity
  1. By Value
4. Hepatotoxicity
  1. By Value
5. Neurotoxicity
  1. By Value
6. Other Toxicities
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Cell Culture Technology
    1. By Value
  3. High-Throughput Screening (HTS)
    1. By Value
  4. Molecular Imaging Technology
    1. By Value
  5. OMICS Technology
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Cellular Assay
    1. By Value
  3. Biochemical Assay
    1. By Value
  4. In-Silico
    1. By Value
  5. Ex-Vivo
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Systemic Toxicity
    1. By Value
  3. Renal Toxicity
    1. By Value
  4. Hepatotoxicity
    1. By Value
  5. Neurotoxicity
    1. By Value
  6. Other Toxicities
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Cell Culture Technology
  1. By Value
3. High-Throughput Screening (HTS)
  1. By Value
4. Molecular Imaging Technology
  1. By Value
5. OMICS Technology
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Cellular Assay
  1. By Value
3. Biochemical Assay
  1. By Value
4. In-Silico
  1. By Value
5. Ex-Vivo
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Systemic Toxicity
  1. By Value
3. Renal Toxicity
  1. By Value
4. Hepatotoxicity
  1. By Value
5. Neurotoxicity
  1. By Value
6. Other Toxicities
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Cell Culture Technology
    1. By Value
  3. High-Throughput Screening (HTS)
    1. By Value
  4. Molecular Imaging Technology
    1. By Value
  5. OMICS Technology
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Cellular Assay
    1. By Value
  3. Biochemical Assay
    1. By Value
  4. In-Silico
    1. By Value
  5. Ex-Vivo
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Systemic Toxicity
    1. By Value
  3. Renal Toxicity
    1. By Value
  4. Hepatotoxicity
    1. By Value
  5. Neurotoxicity
    1. By Value
  6. Other Toxicities
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

ADME Toxicology Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Promega Corporation
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
PerkinElmer Inc.
Agilent Technologies
Corning Inc.
Bio-Rad Laboratories
Covance Inc.
Charles River Laboratories
Eurofins Scientific
Thermo Fisher Scientific
GE Healthcare
Cyprotex
Evotec AG

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment